RELENZA NEWS HIGHLIGHTS Media Articles Related to Relenza (Zanamivir)
New Warnings for Flu Drug Relenza Source: MedicineNet oseltamivir Specialty [2008.04.03]
Influenza vaccine effective in young children (Reuters) Source: Y! Health Cold & Flu News [2008.11.26]
Start Of Phase III Trial On The Anti-influenza Drug CS-8958 Source: Flu / Cold / SARS News From Medical News Today [2008.11.17]
A New Way To Predict Outbreaks: Replikin Peptide Concentration In H5N1 Influenza Virus Genome As A Marker For Lethal Outbreaks Source: Bird Flu / Avian Flu News From Medical News Today [2008.11.13]
Design Of System That Will Revolutionise Control Of Influenza Epidemics Source: Flu / Cold / SARS News From Medical News Today [2008.11.13]
Published Studies Related to Relenza (Zanamivir)
A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. [2008.01]
Efficacy and Safety of Inhaled Zanamivir in the Prevention of Influenza in Community-Dwelling, High-Risk Adult and Adolescent Subjects: A 28-day, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. [2007.08]
Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. [2003.06]
Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza. [2003]
Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households. [2002.12.01]
Clinical Trials Related to Relenza (Zanamivir)
A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects [Terminated]
A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-Term Prophylaxis Against Pandemic Influenza [Not yet recruiting]
A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-Term Prophylaxis Against Pandemic Influenza: PIPET B [Not yet recruiting]
|